Literature DB >> 26759401

Myxoedema coma in the setting of hyperglycaemic hyperosmolar state.

Alexander Spyridoulias1, Muhammad Shakeel Riaz2.   

Abstract

Decompensated hypothyroidism is a rare endocrine emergency but a differential that should be considered in patients presenting critically unwell with systemic illness. We report a case of myxoedema coma in a woman presenting with respiratory failure, hypotension, hypothermia and a reduced level of consciousness, all of which are poor prognostic features in decompensated hypothyroidism. The patient was admitted to critical care for mechanical ventilation and cardiovascular support and treated with a combination of insulin, liothyronine and levothyroxine, making a good recovery. We wanted to highlight this case of myxoedema coma occurring in the context of a hyperglycaemic hyperosmolar state (HHS), as the former condition is normally associated with hypoglycaemia, hyponatraemia and hypo-osmolality. Decompensated hypothyroidism should be considered in presentations of HHS as well as with other metabolic derangements, as delays in thyroid hormone replacement are associated with poorer outcomes. It has multisystem effects challenging its recognition and we discuss potential complications and their management. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26759401      PMCID: PMC4716335          DOI: 10.1136/bcr-2015-213411

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Effects of intravenous triiodothyronine during coronary artery bypass surgery.

Authors:  Mustafa Güden; Belhhan Akpinar; Ertan Sagğbaş; Ilhan Sanisoğlu; Emine Cakali; Osman Bayindir
Journal:  Asian Cardiovasc Thorac Ann       Date:  2002-09

Review 2.  Thyroid emergencies.

Authors:  Joanna Klubo-Gwiezdzinska; Leonard Wartofsky
Journal:  Med Clin North Am       Date:  2012-02-17       Impact factor: 5.456

3.  Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxine treatment.

Authors:  S Arlot; X Debussche; J D Lalau; A Mesmacque; M Tolani; J Quichaud; A Fournier
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

Review 4.  Hypothyroidism and acquired von Willebrand's syndrome: a systematic review.

Authors:  E Manfredi; B van Zaane; V E A Gerdes; D P M Brandjes; A Squizzato
Journal:  Haemophilia       Date:  2008-01-21       Impact factor: 4.287

Review 5.  Myxedema coma. Pathophysiology, therapy, and factors affecting prognosis.

Authors:  R M Jordan
Journal:  Med Clin North Am       Date:  1995-01       Impact factor: 5.456

6.  Postoperative myxoedema. A report of coma and upper airway obstruction.

Authors:  K M Sherry; I L Hutchinson
Journal:  Anaesthesia       Date:  1984-11       Impact factor: 6.955

7.  Management of hyperosmolar hyperglycaemic state in adults with diabetes.

Authors:  A R Scott
Journal:  Diabet Med       Date:  2015-06       Impact factor: 4.359

8.  Severe angioedema in myxedema coma: a difficult airway in a rare endocrine emergency.

Authors:  Christopher H Lee; Charles R Wira
Journal:  Am J Emerg Med       Date:  2009-10       Impact factor: 2.469

9.  Predictors of outcome in myxoedema coma: a study from a tertiary care centre.

Authors:  Pinaki Dutta; Anil Bhansali; Shriq Rashid Masoodi; Sanjay Bhadada; Navneet Sharma; Rajesh Rajput
Journal:  Crit Care       Date:  2008-01-03       Impact factor: 9.097

10.  Predictors of outcome in myxoedema coma.

Authors:  Jennifer Beynon; Simeen Akhtar; Tara Kearney
Journal:  Crit Care       Date:  2008-01-23       Impact factor: 9.097

View more
  2 in total

1.  Diagnosis of myxedema coma complicated by renal failure: a case report.

Authors:  Akiteru Takamura; Ryusho Sangen; Yoshiki Furumura; Daisuke Usuda; Yuji Kasamaki; Tsugiyasu Kanda
Journal:  Clin Case Rep       Date:  2017-02-21

2.  Case Report: Myxedema Coma Caused by Immunoglobulin A Vasculitis in a Patient With Severe Hypothyroidism.

Authors:  Hiroshi Ito; Kenzo Fukuda; Kenji Ashida; Ayako Nagayama; Tomoki Sako; Kouichiro Mizuochi; Masaharu Kabashima; Satoko Yoshinobu; Shimpei Iwata; Nao Hasuzawa; Sumika Hayashi; Tomoyuki Akashi; Masatoshi Nomura
Journal:  Front Immunol       Date:  2022-02-18       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.